Monday, January 31, 2022

Not Making Headlines...Japan’s Kowa Company Finds Ivermectin is Effective Against Omicron and Other COVID-19 VariantsKowa Company Ltd, a Japanese company specializing in trading and sales of medicines and medical equipment, announced on Monday that Ivermectin has an “antiviral effect” against Omicron and other COVID-19 variants as Phase III clinical trials continue

Not Making Headlines...

Japan’s Kowa Company Finds Ivermectin is Effective Against Omicron and Other COVID-19 Variants

Kowa Company Ltd, a Japanese company specializing in trading and sales of medicines and medical equipment, announced on Monday that Ivermectin has an “antiviral effect” against Omicron and other COVID-19 variants as Phase III clinical trials continue
Gateway Pundit